Intermezzo FDA Approval History
FDA Approved: Yes (Discontinued) (First approved November 23, 2011)
Brand name: Intermezzo
Generic name: zolpidem tartrate
Dosage form: Sublingual Tablets
Company: Purdue Pharma LP
Treatment for: Insomnia
Marketing Status: Discontinued
Intermezzo is a low dose, fast acting, sublingual formulation of the hypnotic agent zolpidem, indicated for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep.
Development timeline for Intermezzo
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.